MTND6P22

Across TCGA pan-cancer cohorts, MTND6P22 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated MTND6P22 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MTND6P22 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MTND6P22 expression acts as an unfavorable survival marker, although some lineages such as COAD and ACC show a favorable association.

COAD, ACC, and THCA are the cancer types where MTND6P22 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	0.713	0.386	.001	57	view →
ACC	OS	Quartile	All	1.000	0.662	.003	32	view →
THCA	OS	Tertile	III,IV	1.000	0.689	.003	31	view →
CHOL	OS	Quartile	All	0.185	0.782	<.001	29	view →
UCEC	OS	Quartile	II,III,IV	0.267	0.740	.009	26	view →
LIHC	OS	Tertile	All	0.659	0.386	<.001	17	view →
STAD	OS	Median	IV	0.642	0.194	.003	15	view →
THYM	DFS	Quartile	All	0.726	0.925	.010	15	view →
TGCT	OS	Quartile	All	0.877	1.000	.006	14	view →
KIRP	DFS	Quartile	All	0.927	0.783	.007	13	view →
LUAD	OS	Median	IV	0.337	0.756	.021	12	view →
READ	OS	Tertile	II,III,IV	0.848	0.474	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

MTND6P22–COAD (DFS)

Open the COAD breakdown →